Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | 0.00% | 0.00% | 0.00% |
Apr. 26 | Appili Therapeutics Inc. announced that it has received CAD 0.3 million in funding | CI |
Apr. 02 | Appili Therapeutics To be Acquired by Aditxt, Inc. | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.24M 3.12M |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.41M | Net income 2025 * | -10M -7.34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-0.65
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.94% |
3 months | +16.67% | ||
6 months | +16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Kenneth Howling
DFI | Director of Finance/CFO | 66 | 21-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 20-01-26 | |
Prakash Gowd
BRD | Director/Board Member | 60 | Nov. 12 |
Director/Board Member | 70 | 21-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.035 | 0.00% | 27,147 |
24-05-16 | 0.035 | 0.00% | 50,502 |
24-05-15 | 0.035 | -12.50% | 17,000 |
24-05-13 | 0.04 | +14.29% | 1,000 |
24-05-10 | 0.035 | 0.00% | 73,000 |
Delayed Quote Toronto S.E., May 17, 2024 at 11:56 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.12M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- APLI Stock